2026-525217-31-00招募中1 期
A Phase 1, Open-Label, Multicenter Study of INCA036978 in Participants With Myeloproliferative Neoplasms
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Incyte Corp.
- 入组人数
- 60
- 试验地点
- 17
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Information
Scientific
Incyte Corp.
研究点 (17)
Loading locations...
相似试验
尚未招募
不适用
BG-C137-101Advanced Solid TumorjRCT203125059119
招募中
不适用
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes (J2A-MC-GZGY)Diabetes Mellitus, Type 2jRCT2031260316170
尚未招募
不适用
A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly diagnosed Adults With B-cell Precursor Acute Lymphoblastic LeukaemiaPhiladelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic LeukemiajRCT2051250262560
招募中
不适用
A Phase 1 Study of MK-4884 for Advanced/Metastatic Solid Tumorsadvanced/metastatic solid tumorsadvanced/metastatic solid tumors (CRC, RCC, NSCLC, BTC)jRCT20312601236
招募中
1 期
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.2023-510356-23-00Novartis Pharma AG76